NEW YORK – Pacific Biosciences on Wednesday morning priced a public offering of common stock that it expects will bring in at least $86.9 million in gross proceeds to the firm.
The Menlo Park, California-based single molecule sequencing technology company is offering 6,096,112 shares of common stock at $14.25 per share. PacBio also granted the underwriters of the offering a 30-day option to purchase up to an additional 914,416 shares of its common stock at the public offering price.